Skip to main content

Abstract

Melancholia has accounted for severe human suffering throughout history. Numerous individuals have poignantly described the various symptoms and feelings that accompany severe depressions. However, it was not until the beginning of the 20th century that both psychological and constitutional theories were developed. Abraham postulated intense oral fixation in depressed individuals and differentiated grief from morbid depression.1 Moreover, he viewed depression as aggression turned toward the self. Freud embraced these ideas but elaborated the concept of object loss.2 He contended that the real or fantasied loss of an ambivalently loved person precipitates an ego regression with introjection and intense anger toward the lost object. This process results in self-deprecating, guilty feelings. Many authorities have argued that depression is not simply the result of aggression turned inward. Overt expressions of hostility do not relieve depressive symptoms. Weissman et al. emphasize that depression and aggression are separate affects that frequently coexist in depressed individuals.3

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham K.: Notes on the Psychoanalytic Investigation and Treatment of Manic-depressive Insanity and Allied Conditions (1911). New York, Basic Books, 1960, pp 137–156.

    Google Scholar 

  2. Freud S.: Mourning and Melancholia, Standard Edition (1916). London, Hogarth Press, 1971, vol XIV.

    Google Scholar 

  3. Weissman M. M., Fox K., Klerman C.: Hostility and depression associated with suicide attempts. Am J Psychiatry 130;450–455, 1973.

    PubMed  CAS  Google Scholar 

  4. Bibring E.: The mechanism of depression, in Greenacre P. (ed): Affective Disorders. New York, International Universities Press, 1965, pp 13–48.

    Google Scholar 

  5. Harlow H., Harlow M.: Learning to love. Sci Am 54:244–272, 1966.

    CAS  Google Scholar 

  6. Spitz R.: Anaclitic depression. An inquiry into the genesis of psychiatric conditions in early childhood. Psychoanal Study Child 2:313–342, 1942.

    Google Scholar 

  7. Ainsworth M.: Object relations, dependency and attachment. Child Dev 40:969–1025, 1969.

    Article  PubMed  CAS  Google Scholar 

  8. Bowlby J.: Childhood mourning and its implications for psychiatry. Am J Psychiatry 118:481–498, 1961.

    PubMed  CAS  Google Scholar 

  9. Robertson J., Robertson J.: Young children in brief separation: A fresh look. Psychoanal Study Child 26:264–315, 1971.

    PubMed  CAS  Google Scholar 

  10. Mahler M. S.: On sadness and grief in infancy and childhood: Loss and restoration of the symbiotic love object. Psychoanal Study Child 16:332–351, 1961.

    Google Scholar 

  11. Kohut H.: The Analysis of the Self. New York, International Universities Press, 1971.

    Google Scholar 

  12. Kernberg O.: Borderline Conditions and Pathological Narcissism. New York, Jason Aronson, 1975.

    Google Scholar 

  13. Beck A. T., Rush A. J., Shaw B., et al: Cognitive Therapy of Depression. New York, Guilford Press, 1979, pp 1–34.

    Google Scholar 

  14. Seligman M., Maier S., Geer J.: The alleviation of learned helplessness and the dog. J Abnorm Soc Psychol 73:256–262, 1968.

    Article  CAS  Google Scholar 

  15. Lewinsohn P., Biglar A., Zeiss A.: Behavioral treatment of depression, in Davidson P (ed): The Behavioral Management of Anxiety, Depression and Pain, New York, Brunner-Mazel, 1976, pp 91–146.

    Google Scholar 

  16. Decker E.: The Revolution in Psychiatry. London, Collier-Macmillan, 1964, pp 108–135.

    Google Scholar 

  17. Schildkraut J. J.: Catecholamine hypothesis of affective disorder. Am J Psychiatry 122:509–522, 1965.

    PubMed  CAS  Google Scholar 

  18. Maas J. W.: Biogenic amines and depression: Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry 32:1357–1367, 1975.

    Article  PubMed  CAS  Google Scholar 

  19. Bunney W. E., Murphy D. L., Goodwin F. K., et al: The “switch process” in manic-depressive illness. I. A systematic study of sequential behavioral changes. Arch Gen Psychiatry 27:295–317, 1972.

    Article  PubMed  Google Scholar 

  20. Akiskal H. S., McKinney W. I. Jr: Overview of recent research in depression; integration of ten conceptual models into a comprehensive clinical frame. Arch Gen Psychiatry 32:285–305, 1975.

    Article  PubMed  CAS  Google Scholar 

  21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised (DSM-IIIR). Washington, American Psychiatric Association, 1987.

    Google Scholar 

  22. Kocsis J. H., Frances A. J., Voss C., et al: Imipramine treatment for chronic depression. Arch Gen Psychiatry 45:253–257, 1988.

    Article  PubMed  CAS  Google Scholar 

  23. Brotman A. W., Falk W. E., Gelenberg A. J.: Pharmacologic treatment of acute depressive subtypes, in Meltzer H (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1031–1040.

    Google Scholar 

  24. Brotman A. W., Falk W. E., Gelenberg A. J.: Pharmacologic treatment of acute depressive subtypes, in Meltzer H (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1031–1940.

    Google Scholar 

  25. Weissman M. M.: The psychological treatment of depression. Arch Gen Psychiatry 36:1261–1268, 1979.

    Article  PubMed  CAS  Google Scholar 

  26. Weissman M. M., Prusoff B. A., DiMascio A., et al: The efficacy of drugs and psychotherapy in the treatment of acute depression episodes. Am J Psychiatry 136:555–558, 1979.

    PubMed  CAS  Google Scholar 

  27. Herceg-Baron R. L., Prusoff B. A., Weissman M. M., et al: Pharmacotherapy and psychotherapy in acute depressed patients. A study of attrition patterns in a clinical trial. Compr Psychiatry 20:315–325, 1979.

    Google Scholar 

  28. Weissman M. M., Klerman G. L., Prusoff B. A., et al: Depressed outpatients: Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 38:51–55, 1981.

    Article  PubMed  CAS  Google Scholar 

  29. Kovacs M.: The efficacy of cognitive and behavior therapies for depression. Am J Psychiatry 137:1495–1501, 1980.

    PubMed  CAS  Google Scholar 

  30. Frankel F. H.: Current perspectives on ECT: A discussion. Am J Psychiatry 134:1014–1019, 1977.

    PubMed  CAS  Google Scholar 

  31. Grahme-Smith D. S., Green A. R., Costain D. W.: Mechanism of the antidepressant action of electroconvulsive therapy. Lancet 1:254–256, 1978.

    Article  Google Scholar 

  32. Small J. G., Kellams J. J., Milstein V., et al: Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry 15:103–112, 1980.

    PubMed  CAS  Google Scholar 

  33. Mandel M. R., Madsen J., Miller A. L., et al: Intoxication associated with lithium and ECT. Am J Psychiatry 137:1107–1109, 1980.

    PubMed  CAS  Google Scholar 

  34. Squire L. R., Slater P. C.: Bilateral and unilateral ECT: Effects on verbal and nonverbal memory. Am J Psychiatry 135:1316–1320, 1978.

    PubMed  CAS  Google Scholar 

  35. Fink, M.: An adequate treatment? Editorial. Convulsive Therapy 5:311–313, 1989.

    PubMed  Google Scholar 

  36. Baldessarini R. J.: The basis for amine hypothesis in affective disorders. A critical evaluation. Arch Gen Psychiatry 32:1087–1093, 1975.

    Article  PubMed  CAS  Google Scholar 

  37. Wilson E. G., Petrie W. M., Ban T. A.: Possible lack of anticholinergic effects with mianserin: A pilot study. J Clin Psychiatry 41:63–65, 1980.

    PubMed  CAS  Google Scholar 

  38. Sulser F.: New perspectives on the mode of action of antidepressant drugs. Trends Pharmacol Sci 1:92–94, 1979.

    Article  CAS  Google Scholar 

  39. Crews F. T., Smith C. B.: Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 202:322–324, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. deMontigny C., Aghajanian G. K.: Tricyclic antidepressant: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303–1306, 1978.

    Article  CAS  Google Scholar 

  41. Briley S., Langer S. Z., Raisman R., et al: Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 202:303–305, 1980.

    Article  Google Scholar 

  42. Janowsky D., El-Yousef K., Davis M., et al: A cholinergic adrenergic hypothesis of mania and depression. Lancet 2:632–635, 1972.

    Article  PubMed  CAS  Google Scholar 

  43. Maas J. W.: Neurotransmitters in depression: Too much, too little or too unstable? Trends Neurosci 2:306–308, 1979.

    Article  Google Scholar 

  44. Jefferson J. W.: Cardiovascular effects and toxicity of anxiolytics and antidepressants. J Clin Psychiatry 50:368–378, 1989.

    PubMed  CAS  Google Scholar 

  45. Glassman A. H., Roose S. P.: Cardiovascular effects of tricyclic antidepressants. Psychiatr Ann 17:340–347, 1987.

    Google Scholar 

  46. Davidson J.: Seizures and bupropion: A review. J Clin Psychiatry 50:256–261, 1989.

    PubMed  CAS  Google Scholar 

  47. Lipinski J. F., Mallya G., Zimmerman P., Pope H.: Fluoxetine-induced akathisia: Clinical and theoretical implications. J Clin Psychiatry 50:339–342, 1989.

    PubMed  Google Scholar 

  48. Preskorn S. H., Othmer S. C.: Evaluation of bupropion hydrochloride: The first of a new class of atypical antidepressants. Pharmacotherapy 4:20–34, 1984.

    PubMed  CAS  Google Scholar 

  49. Treatment of xerostomia. Med Lett 30:74–76, 1988.

    Google Scholar 

  50. Vaughan D. A.: Interaction of fluoxetine with tricyclic antidepressants. Letter to editor. Am J Psychiatry 145:1478, 1988.

    PubMed  CAS  Google Scholar 

  51. Sternbach H.: Danger of MAOI therapy after fluoxetine withdrawal. Letter to editor. Lancet 2:850–851, 1988.

    Article  PubMed  CAS  Google Scholar 

  52. Boehnert M. T., Lovejoy F. H. Jr.: Value of the QRS duration vs the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 313:474–479, 1985.

    Article  PubMed  CAS  Google Scholar 

  53. Foulke G. E., Albertson T. E.: QRS interval in tricyclic antidepressant overdose: Inaccuracy as a toxicity indicator in emergency setting. Ann Emerg Med 16:160–163, 1987.

    Article  PubMed  CAS  Google Scholar 

  54. Crome P., Dawling S., Braithwaite R. A., et al. : Effect of activated charcoal on absorption of nortriptyline. Lancet 2:1203–1205 , 1977.

    Article  PubMed  CAS  Google Scholar 

  55. Granacher R. D., Baldessarini R. J.: Physostigmine: Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry 32:375–379, 1975.

    Article  PubMed  CAS  Google Scholar 

  56. Gelenberg A. J.: MAOIs: Assorted concerns. Biol Ther Psychiatry 11:33–36, 1988.

    Google Scholar 

  57. Clary C., Schweizer E.: Treatment of MAOI hypertensive crisis with sublingual nifedipine. J Clin Psychiatry 48:249–250, 1987.

    PubMed  CAS  Google Scholar 

  58. Teicher M. H., Cohen B. M., Baldessarini R. J., et al: Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry 145:1552–1556, 1988.

    PubMed  CAS  Google Scholar 

  59. Zimmerman H. J., Ishak K. G.: The hepatic injury of monoamine oxidase inhibitors. J Clin Psychopharmacol 7:211–213, 1987.

    PubMed  CAS  Google Scholar 

  60. Dilsaver S. C.: Monoamine oxidase inhibitor withdrawal phenomena: Symptoms and pathophysiology. Acta Psychiatr Scand 78:1–7, 1988.

    Article  PubMed  CAS  Google Scholar 

  61. Tollefson G. D.: Monoamine oxidase inhibitors: A review. J Clin Psychiatry 44:280–288, 1983.

    PubMed  CAS  Google Scholar 

  62. Kaplan R. F., Feinglass N. G., Webster W., et al: Phenelzine overdose treated with dantrolene sodium. JAMA 255:642–644, 1986.

    Article  PubMed  CAS  Google Scholar 

  63. Breheny F. X., Dobb G. J., Clarke G. M.: Phenelzine poisoning, case report. Anesthesia 41:53–56, 1986.

    Article  CAS  Google Scholar 

  64. Rosenbaum J. F., Gelenberg A. J.: Drug treatment of resistant depression, in Karasu T. B. (ed): Treatments of Psychiatric Disorders. A Task Force Report of the APA. Washington, American Psychiatry Association, 1989.

    Google Scholar 

  65. Harrison W. M., McGrath P. J., Stewart J. W., Quitkin F.: MAOIs and hypertensive crises: The role of OTC drugs. J Clin Psychiatry 50:64–65, 1989.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gelenberg, A.J., Schoonover, S.C. (1991). Depression. In: Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1137-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1137-0_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1139-4

  • Online ISBN: 978-1-4757-1137-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics